Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amanda Grimes, MD
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S of Alabama
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Benioff Children'S Hospital
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- Alfac Cancer and Blood Disorder Center: Scottish Rite
Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- Riley Hospital for Children-Indiana University
Indianapolis, Indiana, United States
- Boston Children'S Hospital
Boston, Massachusetts, United States
- Children'S Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Columbia University Irving Medical Center
New York, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Randall Children'S Hospital
Portland, Oregon, United States
- the Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Hasbro Children'S Hospital
Providence, Rhode Island, United States
- St. Jude Children'S Hospital
Memphis, Tennessee, United States
- Texas Children'S Hospital
Houston, Texas, United States
- University of Wisconsin
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 May 2019
- Primary completion
- 17 Apr 2024
- Completion
- 26 Feb 2025
- Last update posted
- 29 Jul 2025
- Registered enrollment
- 122
- Registry id
- NCT03939637
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.